Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000945

Drug Information
NameClenbuterol
SynonymsClenbuterol (INN); KBio2_007180; 4-Amino-3,5-dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol; AB00053680; NCGC00163150-02; nchembio.307-comp6; SPBio_002330; 37148-27-9; KBioGR_001518; IDI1_000794; D07713; Spectrum4_001099; NCGC00163150-01; (+)-4-Amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol; Planipart; 4-Amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol; Clenbuterol [BAN:INN]; clenbuterol; Prestwick1_000345; Planipart [veterinary] (TN); CHEMBL49080; CID2783; AC1L1EGH; LS-30602; BRN 1076467; NCGC00163150-04; Clenbuterolum; MolPort-003-845-975; HMS2089I15; DB01407; NCGC00163150-03; UNII-XTZ6AXU7KN; Benzyl alcohol, 4-amino-alpha-((tert-butylamino)methyl)-3,5-dichloro-; (+-)-clenbuterol; KBioSS_002044; KBio3_001829; Benzenemethanol, 4-amino-3,5-dichloro-.alpha.-[[(1,1-dimethylethyl)amino]methyl]-; 1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino]ethanol; KBio2_002044; BENZENEMETHANOL, 4-AMINO-3,5-DICHLORO-alpha-(((1,1-DIMETHYLETHYL)AMINO)METHYL)-; BPBio1_000451; KBio2_004612; Spectrum4_000743; Spectrum5_001497; NAB-365; 50306-03-1; BSPBio_002609; BSPBio_000409; Prestwick2_000345; (-)-4-Amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol; 1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol; C12H18Cl2N2O; KBio1_000794; AC-10284; Prestwick3_000345; 50499-60-0; BRD-A75726477-003-04-9; 1-(4-Amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol; EINECS 253-366-0; NINDS_000794; DivK1c_000794; Prestwick0_000345; Contraspasmin (TN); Planipart [veterinary]; EINECS 256-608-3; Spectrum_001564; Spectrum3_000975; Clenbuterolum [INN-Latin]; CHEBI:174690; KBioGR_001066; EINECS 256-531-5; Contraspasmin
IndicationChronic breathing disorders
[ICD9: 490-496   ICD10: J44-J47]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C12H18Cl2N2O/c1-12(2,3)16-6-10(17)7-4-8(13)11(15)9(14)5-7/h4-5
,10,16-17H,6,15H2,1-3H3
InChIKeySTJMRWALKKWQGH-UHFFFAOYSA-N
Canonical SMILESCC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O    
Therapeutic ClassBronchodilator Agents
CAS NumberCAS 37148-27-9
FormulaC12H18Cl2N2O
PubChem Compound IDCID 2783.
PubChem Substance IDSID 179024.
SuperDrug ATC IDR03AC14; R03CC13
SuperDrug CAS ID037148279;
TargetBeta-2 adrenergic receptorAgonist[2][3]
Ref 1Drug information of Clenbuterol, 2008 To Reference
Ref 2Postischemic brain injury is attenuated in mice lacking the beta2-adrenergic receptor. Anesth Analg. 2009 Jan;108(1):280-7. To Reference
Ref 3Beta(2)-adrenoceptor stimulation enhances latent transforming growth factor-beta-binding protein-1 and transforming growth factor-beta1 expression in rat hippocampus after transient forebrain ischemia. Neuroscience. 2001;107(4):593-602. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543